Pressure Point Inc. is a leader in wrist acupressure design development to prevent nausea and vomiting. The company has developed Pressure Right®, an acupressure emetic-management, adhesive wrist device, which is used to enhance the effectiveness of antiemetic prophylactic drug combinations in preventing postoperative nausea and vomiting (PONV).
In a peer-reviewed randomized, double-blinded study appearing in the Anesthesia-Analgesia Journal, April 2012, the study endpoint results clearly support the use of Pressure Right® as a primary intervention tool in preventing PONV in high-risk patients.
The evidence-based research of the study data showed an overall improvement in patient satisfaction outcomes, with several endpoint measurements reaching statistical significance for Pressure Right® study patients.
Pressure Right® achieved 510(k) premarket (Rx) clearance from the US Food and Drug Administration in April 2011. Pressure Right® is intended to be applied pre-operatively to patients’ wrists (prior to the induction of anesthesia) with no related adverse effects.